AcelRx Pharmaceuticals EPS Diluted TTM:
-1.501 for Dec. 31, 2012AcelRx Pharmaceuticals Historical EPS Diluted TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -1.501 |
| Sept. 30, 2012 | -1.415 |
| June 30, 2012 | -1.335 |
| March 31, 2012 | -1.235 |
| Dec. 31, 2011 | -1.175 |
| Sept. 30, 2011 | -6.075 |
| June 30, 2011 | -11.15 |
| March 31, 2011 | -16.31 |
| Dec. 31, 2010 | -21.86 |
| Sept. 30, 2010 | -51.57 |
About Earnings Per Share (TTM)
ACRX EPS Diluted TTM Benchmarks
| Companies | |
|---|---|
| Astex Pharmaceuticals | 0.0448 |
| Cyanotech Corporation | 0.4746 |
| Intercept Pharmaceuticals |
ACRX EPS Diluted TTM Range, Past 5 Years
| Minimum | -51.57 | Sep 2010 |
| Maximum | -1.175 | Dec 2011 |
| Average | -11.36 |
ACRX News
Canaccord Boosts PT on AcelRx (ACRX) to $11; On Track for Sufentanil NDA Submission by Q313
Street Insider 9:22 AM
Street Insider 9:22 AM
AcelRx Pharma (ACRX) Stock Higher; Sufentanil NanoTab Study Meets Primary Endpoint
Street Insider May 21
Street Insider May 21
